Back

dr. H.A. (Richard) van Wijk

dr. H.A. (Richard) van Wijk

Associate Professor
  • Central Diagnostic Laboratory

Research Programs

Biography

Biography

Richard van Wijk did his PhD in 2004 in UMC Utrecht on molecular mechanisms of disease in hereditary red blood cell enzymopathies. Currently he holds a position of Associate Professor at the Department Central Diagnostic Laboratory of the UMC Utrecht. He combines diagnostics, consultancy, and (translational) research activities on rare hereditary disorders of the red blood cell, affecting its production, function, or survival. Under his supervision the Central Diagnostic Laboratory has established itself as a National and International Center of Expertise for diagnosis and research on rare red blood cell disorders. Novel advanced and state-of-the art laboratory methods and the concept of ‘personalized diagnostics’ are applied to diagnosing and investigating patients with such disorders. Because of their rarity, the pathophysiology of many of these disorders is poorly understood. The key element of his research therefore is to gain a better understanding of pathophysiology and genotype-to-phenotype correlations, and the identification of novel (modifier) genes.

Side Activities

  • Member of the European Hematology Organisation (EHA; member 6775).
  • Member of EHA Scientific Working Group on Red Cells and Iron (member SWG-202108-00993).
  • Member of the Dutch Hematology Association (NVvH).
  • Member of the Dutch Society for Hematological Laboratory Investigation (VHL).
  • Member of the working group ‘Non-oncological Hematology’of the Dutch

Hematology Association (NVvH).

 

  • Member of the Scientific Advisory Board on PKD of the Rare Anaemias Disorders European Epidemiological Platform (RADEEP)

 

  • Consultant for Agios Pharmaceuticals Inc. (Cambridge, MA, USA)
  • Consultant and Scientific advisory board for Global Blood Therapeutics

 

  • Reviewer for peer reviewed journals, i.e. Blood, British Journal of Haematology, Blood Advances, Haematologica, International Journal of Molecular Sciences, European Journal of Haematology, International Journal of Laboratory Haematology, Journal of Pediatric Hematology and Oncology
  • Abstract reviewer for the annual Congress of the EHA (2011 – present).
  • Reviewer for Genetics Home Reference at the U.S. National Library of Medicine 
  • Reviewer for National Information Centre for Metabolic Diseases Climb (Children Living with Inherited Metabolic Diseases), UK
  • Reviewer for Orphanet Professional Encyclopedia

 

  • Associate editor of Red Blood Cell Physiology (specialty section of Frontiers In Physiology
  • Topic editor of Frontiers in Physiology Research Topic - Pathophysiology of Rare Hemolytic Anemias
  • Topic editor of Frontiers in Physiology Research Topic - Novel Diagnostic Devices for Red Blood Cell Related Diseases / New Methods for Red Blood Cell Research

Research Output (129)

A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia

van Dijk Myrthe J., van Oirschot Brigitte A., Harrison Alexander N., Recktenwald Steffen M., Qiao Min, Stommen Amaury, Cloos Anne Sophie, Vanderroost Juliette, Terrasi Romano, Dey Kuntal, Bos Jennifer, Rab Minke A.E., Bogdanova Anna, Minetti Giampaolo, Muccioli Giulio G., Tyteca Donatienne, Egée Stéphane, Kaestner Lars, Molday Robert S., van Beers Eduard J., van Wijk Richard Dec 2023, In: American Journal of Hematology. 98 , p. 1877-1887 11 p.

One-year safety and efficacy of mitapivat in sickle cell disease:follow-up results of a phase 2, open-label study

van Dijk Myrthe J, Rab Minke A E, van Oirschot Brigitte A, Bos Jennifer, Derichs Cleo, Rijneveld Anita W, Cnossen Marjon H, Nur Erfan, Biemond Bart J, Bartels Marije, Jans Judith J M, van Solinge W W, Schutgens Roger E G, van Wijk Richard, van Beers Eduard J 7 Nov 2023, In: Blood Advances. 7 , p. 7539-7550

Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias:Shedding new light on an old enzyme

van Dijk Myrthe J, de Wilde Jonathan R A, Bartels Marije, Kuo Kevin H M, Glenthøj Andreas, Rab Minke A E, van Beers Eduard J, van Wijk Richard 12 Jun 2023, In: Blood Reviews. 61

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Joosse Huibert Jan, van Oirschot Brigitte A., Kooijmans Sander A.A., Hoefer Imo E., van Wijk Richard A.H., Huisman Albert, van Solinge Wouter W., Haitjema Saskia 7 Jun 2023, In: Scientific Reports. 13

Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia

de Wilde Jonathan R A, van Dooijeweert Birgit, van Vuren Annelies J, Huisman Elise J, Smiers Frans J, van der Veer Arian, van Wijk Richard, van Solinge Wouter W, Nieuwenhuis Edward E S, van Beers Eduard J, Bartels Marije Nov 2022, In: EJHaem. 3 , p. 1300-1304 5 p.

Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis:A case series and literature review

van Dijk Myrthe J, van Oirschot Brigitte A, Stam-Slob Manon C, Waanders Esmé, van der Zwaag Bert, van Beers Eduard J, Jans Judith J M, van der Linden Peter Willem, Torregrosa Diaz Jose M, Gardie Betty, Girodon François, Schots Rik, Thielen Noortje, van Wijk Richard 30 Sep 2022, In: British Journal of Haematology. 200 , p. 249-255 7 p.

The use of next-generation sequencing in the diagnosis of rare inherited anaemias:A Joint BSH/EHA Good Practice Paper

Roy Noémi B A, Da Costa Lydie, Russo Roberta, Bianchi Paola, Mañú-Pereira Maria Del Mar, Fermo Elisa, Andolfo Immacolata, Clark Barnaby, Proven Melanie, Sanchez Mayka, van Wijk Richard, van der Zwaag Bert, Layton Mark, Rees David, Iolascon Achille, 6 Jun 2022, In: British Journal of Haematology. 198 , p. 459-477 19 p.

The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias:A Joint BSH/EHA Good Practice Paper

Roy Noémi B A, Da Costa Lydie, Russo Roberta, Bianchi Paola, Del Mar Mañú-Pereira Maria, Fermo Elisa, Andolfo Immacolata, Clark Barnaby, Proven Melanie, Sanchez Mayka, van Wijk Richard, van der Zwaag Bert, Layton Mark, Rees David, Iolascon Achille 6 Jun 2022, In: HemaSphere. 6 , p. 1-9

Proton pump inhibition for secondary hemochromatosis in hereditary anemia:a phase III placebo-controlled randomized cross-over clinical trial.

van Vuren Annelies, Kerkhoffs Jean Louis, Schols Saskia, Rijneveld Anita, Nur Erfan, Peereboom Dore, Gandon Yves, Welsing Paco, van Wijk Richard, Schutgens Roger, van Solinge Wouter, Marx Joannes, Leiner Tim, Biemond Bart, van Beers Eduard 26 Apr 2022, In: American Journal of Hematology. 97 , p. 924-932 9 p.

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease:a phase 2, open-label study

van Dijk Myrthe J, Rab Minke A E, van Oirschot Brigitte A, Bos Jennifer, Derichs Cleo, Rijneveld Anita W, Cnossen Marjon H, Nur Erfan, Biemond Bart J, Bartels Marije, Jans Judith J M, van Solinge Wouter W, Schutgens Roger E G, van Wijk Richard, van Beers Eduard J 5 Apr 2022, In: American Journal of Hematology. 97 , p. E226-E229

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not